Skip to main content
. 2019 Nov 11;16:212. doi: 10.1186/s12974-019-1606-1

Table 1.

Clinical features of patients and controls

Control PD P value
Socio-demographic and clinical characteristics
 Age at inclusion¢ 55.59 ± 10.22 60.81 ± 10.23 0.064
 Male:female ratio^ 54:46 56:44
 Body mass index (BMI)¢ 26.85 ± 3.89 27.52 ± 4.54 0.549
 Symptom duration (years)¢ NA 2.90 ± 3.14
 Tremoric:akinetic ratio^ NA 59.4:53.1
Clinical scales¢
 Hoehn & Yahr NA 2.17 ± 0.88
 UPDRS I 0.72 ± 0.98 2.50 ± 1.60 < 0.0001***
 UPDRS II 0.32 ± 0.89 13.28 ± 6.56 < 0.0001***
 UPDRS III 1.72 ± 3.71 35.68 ± 18.29 < 0.0001***
 UPDRS IV 0 ± 0 0 ± 0 > 0.999
 Total UPDRS 2.77 ± 4.05 51.59 ± 25.13 < 0.0001***
 Schwab-England scale 99.54 ± 2.13 76.59 ± 22.55 < 0.0001***
 Beck’s depression test 5.54 ± 6.24 11.50 ± 8.00 0.003**
Non-motor symptoms^
 Sialorrhea NA 25
 Sleep disturbance NA 50
 Hyposmia NA 25
 Depression NA 50
 Falls NA 25
Comorbidities^
 Diabetes mellitus type 2 13.6 12.5 0.999
 Hypertension 9.1 37.5 0.029*
 Dyslipidemia 0 12.5 0.141
 Depressive disorder 3.1 6.25 0.557

¢Values are expressed as mean ± SD

^Values are expressed as percentage of subjects

*P < 0.05 is considered as significant

** P < 0.005 is considered as significant

***P < 0.0005 is considered as significant